Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$42.30 USD
-1.60 (-3.64%)
Updated May 8, 2024 04:00 PM ET
After-Market: $42.26 -0.04 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2024
Time: -- |
6/2024 | $-0.36 | 51.30% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.54 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for APLS's next earnings release expected on July 29, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 64.71%.
Earnings History
Price & Consensus
Zacks News for APLS
Apellis Pharmaceuticals (APLS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services